SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2018$1,000
-93.3%
353
-82.4%
0.00%
-100.0%
Q3 2014$15,000
-21.1%
2,0000.0%0.01%
-11.1%
Q2 2014$19,000
+11.8%
2,0000.0%0.01%
+80.0%
Q1 2014$17,000–2,000–0.01%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2014
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders